Sigma HealthcareASX:SIG -1.07%59 Current Ratio is 1.67 as of Dec. 2025, which is 11% above its 10-year median of 1.50. GuruFocus rates ASX:SIG with a GF Score™ of 59/100 and a GF Value™ of A$0.37 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 118 Medical Distribution companies, Sigma Healthcare ranks better than 67.8% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Sigma Healthcare's current ratio for the quarter that ended in Dec. 2025 was 1.67.
Sigma Healthcare has a current ratio of 1.67. It generally indicates good short-term financial strength.
The historical rank and industry rank for Sigma Healthcare's Current Ratio or its related term are showing as below:
ASX:SIG'
s Current Ratio Range Over the Past 10 Years
Min: 1.16 Med: 1.5 Max: 2.46
Current: 1.67
During the past 13 years, Sigma Healthcare's highest Current Ratio was 2.46. The lowest was 1.16. And the median was 1.50.
ASX:SIG's Current Ratio is ranked better than 67.8% of 118
companies
in the Medical Distribution industry
Industry Median: 1.395
vs ASX:SIG: 1.67
Sigma Healthcare (ASX:SIG) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Sigma Healthcare Current Ratio Related Terms
Sigma Healthcare Current Ratio Historical Data
* Premium members only.
The historical data trend for Sigma Healthcare's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:SIG vs MCK, COR, CAH: Current Ratio Comparison
For the Medical Distribution subindustry, Sigma Healthcare's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sigma Healthcare Current Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sigma Healthcare's Current Ratio distribution charts can be found below:
* The bar in red indicates where Sigma Healthcare's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sigma Healthcare (ASX:SIG) has a Current Ratio of 1.67 as of Dec. 2025. This is 11% above median its historical median of 1.50. Over the past decade, Sigma Healthcare's Current Ratio has ranged from 1.16 to 2.46. According to the industry distribution chart, Sigma Healthcare ranks #38 out of 118 companies in the Medical Distribution industry, placing it in the top 32.2%.
Is Sigma Healthcare's Current Ratio too high?
Sigma Healthcare's current Current Ratio of 1.67 is 11% above median its 10-year median of 1.50. Over the past 10 years, this metric has ranged from a low of 1.16 to a high of 2.46. The Medical Distribution industry median Current Ratio is 1.40. Sigma Healthcare's value of 1.67 is 19.7% above this industry median. Based on the distribution chart, Sigma Healthcare ranks #38 out of 118 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Sigma Healthcare has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sigma Healthcare's Current Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sigma Healthcare ranks #38 out of 118 companies for Current Ratio. This puts Sigma Healthcare in the upper half of its industry. The industry median Current Ratio is 1.40. Sigma Healthcare's value of 1.67 is 19.7% above this benchmark. Historically, Sigma Healthcare's own Current Ratio has ranged from 1.16 to 2.46 over the past decade. While the company's 10-year median is 1.50 vs. the industry median of 1.40, Sigma Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Distribution company?
The median Current Ratio among Medical Distribution companies is 1.40, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sigma Healthcare's current Current Ratio of 1.67 is 19.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median Current Ratio is 1.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sigma Healthcare's current Current Ratio is 1.67, which is 11% above median its own 10-year median of 1.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigma Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sigma Healthcare (ASX:SIG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.37, compared to a current price of A$2.77 — trading 648.6% above its estimated fair value. The current Current Ratio is 1.67, which is 11% above median its 10-year median of 1.50 and 19.7% above the Medical Distribution industry median of 1.40. Sigma Healthcare's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Sigma Healthcare (ASX:SIG), the current Current Ratio is 1.67 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sigma Healthcare (ASX:SIG) Overvalued in 2026?
Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued.
The current stock price of A$2.77 is trading 648.6% above its estimated GF Value™ of A$0.37.
GuruFocus considers Sigma Healthcare to be Significantly Overvalued.
Key valuation signals for ASX:SIG:
Current Ratio: 1.67 (11% above median its 10-year median of 1.50)
GF Value™: A$0.37 vs. price of A$2.77 (648.6% above fair value)
Industry Position: 19.7% above the Medical Distribution median (#38 of 118)
No single metric tells the full story. See the ASX:SIG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.
59GF Score
Get the complete analysis for ASX:SIG
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:SIG has been successfully added to your 
